Medical Device Network on MSN19h
FDA authorises Visby Medical’s at-home test for common STIsThe US Food and Drug Administration (FDA) has authorised the first at-home PCR STI test for chlamydia, gonorrhoea, and ...
President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...
The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and ...
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
The US Food and Drug Administration (FDA) granted marketing authorization to Visby Medical for the Visby Medical Women’s Sexual Health Test. This is the first diagnostic test for chlamydia, gonorrhoea ...
The FDA reviewed this test under the FDA’s De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk ...
Only seven jurisdictions are still reporting high flu activity, and for COVID, wastewater detections returned to the low ...
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and ...
The US Food and Drug Administration (FDA) today approved the first at-home, over-the-counter test for chlamydia, gonorrhea, and trichomoniasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback